Advertisement

Topics

Technologiepark Heidelberg GmbH Company Profile

12:53 EDT 20th June 2018 | BioPortfolio

International Science Park with focus on Life Sciences Located close to the University of Heidelberg and to international research institutes [for example: Deutsches Krebsforschungszentrum (DKFZ), European Molecular Biology Laboratory (EMBL), Max-Planck-Institut, Zentrum für Molekulare Biologie Heidelberg (ZMBH)] Founded in 1985 Offer: about 50.000 sqm lab and office space Tenants ompanies/institutions): 63 .

Location

Marktplatz 10
Heidelberg
D-69117
Germany

Contact

Phone: 0049/6221/58-20500
Fax: 0049/6221/58-20990
Email: klaus.plate@heidelberg.de


News Articles [232 Associated News Articles listed on BioPortfolio]

Heidelberg Pharma schließt Lizenzvertrag mit Universität von Texas MD Anderson Cancer Center ab

Bad Marienberg - Die Heidelberg Pharma AG (ISIN DE000A11QVV0/ WKN A11QVV) gab heute den Abschluss eines Lizenzvertrags zwischen ihrer Tochtergesellschaft Heidelberg Pharma Research GmbH und der Uni...

Heidelberg Pharma: Lizenz- und Forschungsdeal mit Magenta Therapeutics

Heidelberg Pharma hat mit Magenta Therapeutics eine Kooperation im Bereich der Wirkstoffforschung vereinbart. "Heidelberg Pharma Research GmbH unterzeichnete die Vereinbarung, bei der aus Magentas ...

Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement

Heidelberg Pharma AG and Magenta Therapeutics Inc., a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more patients, announced the si...

Heidelberg Pharma: Anfang 2019 wird es spannend - Exklusiv-Interview

Nach zwei Kapitalerhöhungen ist Heidelberg Pharma bis 2020 durchfinanziert. Im Exklusivinterview mit der Redaktion von www.4investors.de erläutert Jan Schmidt-Brand, Vorstandschef von Heidelberg Ph....

DGAP-Gesamtstimmrechtsmitteilung: Heidelberg Pharma AG (deutsch)

Heidelberg Pharma AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Heidelberg Pharma AG / Veröffentlic....

#jobs #lifescience EMBL: Project Manager – Heidelberg Center for Human Bioinformatics (HD-HuB)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: EMBL: Project Manager – Heidelberg Center for Human Bioinformatics (HD-...

Heidelberg Pharma AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Heidelberg Pharma AG 05.02.2018 / 12:37 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this...

Epigenetic analysis: Giving the right name to a tumor

(Heidelberg University Hospital and Medical Faculty) Scientists from the 'Hopp Children's Cancer Center at the NCT Heidelberg' (KiTZ) and the Neuropathology Department at Heidelberg University Hospita...

PubMed Articles [30 Associated PubMed Articles listed on BioPortfolio]

Impact of the choice of reference genome on the ability of the core genome SNV methodology to distinguish strains of Salmonella enterica serovar Heidelberg.

Salmonella enterica serovar Heidelberg (S. Heidelberg) is one of the top serovars causing human salmonellosis. The core genome single nucleotide variant pipeline (cgSNV) is one of several whole genome...

Optical Coherence Tomography Angiography of Pigmented Paravenous Retinochoroidal Atrophy.

A 58-year-old man with bilateral pigmented paravenous retinochoroidal atrophy (PPRCA) associated with macular coloboma in the right eye underwent color fundus photography and fundus autofluorescence w...

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

46th ESCP symposium on clinical pharmacy "Science meets practice: towards evidence-based clinical pharmacy services", Heidelberg, Germany, October 9th-11th, 2017.

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Clinical Trials [70 Associated Clinical Trials listed on BioPortfolio]

Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

Eligible patients underwent evaluation of ocular surface parameters by Ocular Surface Disease Index (OSDI) and Glaucoma Symptom Scale (GSS) questionnaires, Break Up Time test (BUT), Schirm...

How Well Does the Data Obtained From Heidelberg Edge Perimeter Visual Field Compare to Standard Octopus Visual Field

The purpose of this study is to compare standard automated perimetry (SAP) using the Heidelberg Edge Perimeter (HEP) with the Octopus Visual Field (OVF) analyzer and determine test-retest ...

Measuring Cyclotorsion on Scanning Laser Ophthalmoscopy (SLO)-Fundus Photographs

Pre-Study: Evaluation of the inter- and intrarater reliability of the integrated algorithm by Heidelberg Spectralis for measuring cyclotorsion on SLO-fundus fotographs, and assessment of t...

hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation

The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of ...

Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS

Companies [553 Associated Companies listed on BioPortfolio]

Technologiepark Heidelberg GmbH

International Science Park with focus on Life Sciences Located close to the University of Heidelberg and to international research institutes [for example: Deutsches Krebsforschungszentrum (DKFZ), E...

Heidelberg Pharma GmbH

When working at Boehringer Mannheim (now Roche Diagnostics) from 1987 to 1999, the founders of Heidelberg Pharma, Dr. Dieter Herrmann and Dr. Hans-Georg Opitz, developed technologies and know-how that...

Heidelberg Innovation Fonds Management GmbH

Heidelberg Innovation invests exclusively in Healthcare companies. Focussing on Medical Devices and Specialty Pharma, the firm is recognized as one of the leading venture capital companies specialized...

CONCEPT HEIDELBERG GmbH

CONCEPT HEIDELBERG was founded on 1 April 1978. Since then, its services have been focussing on the fields of pharmaceutical industry (incl. API manufacture), cosmetics industry, medical device and bi...

Stadt Heidelberg

With its glorious natural setting, the harmonious ensemble consisting of castle, old town and river set in the midst of hills, Heidelberg is regarded as one of the most beautiful cities in Germany. Ye...

More Information about "Technologiepark Heidelberg GmbH" on BioPortfolio

We have published hundreds of Technologiepark Heidelberg GmbH news stories on BioPortfolio along with dozens of Technologiepark Heidelberg GmbH Clinical Trials and PubMed Articles about Technologiepark Heidelberg GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Technologiepark Heidelberg GmbH Companies in our database. You can also find out about relevant Technologiepark Heidelberg GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record